多孔机器人辅助简单前列腺切除术当日出院的前瞻性可行性研究
该前瞻性研究纳入48例接受多孔机器人辅助简单前列腺切除术的患者,采用加速康复外科方案及保留膀胱颈技术。83%患者实现当日出院,仅5%在30天内再入院,当日出院组直接成本降低33%,证实该路径安全可行且成本效益良好。
要点
- 多孔机器人辅助简单前列腺切除术当日出院路径可行,83%患者成功实现。
- 当日出院组30天再入院率为5%,术后第一周10%患者急诊或门诊就诊。
- 当日出院直接成本降低33%,收入成本比149%优于住院组的115%。
核心结论
- 多孔机器人辅助简单前列腺切除术联合当日出院路径安全可行,可缩短住院时间并降低成本。
研究设计与样本
- 前瞻性可行性研究,连续纳入48例2021年7月至2025年8月接受多孔机器人辅助简单前列腺切除术的患者,均遵循加速康复外科方案。
主要发现
- 当日出院患者中位手术时间131(115-147)分钟,中位住院时间141(114-173)分钟,出院时中位疼痛评分3(0-4)。
- 2例(5%)30天内再入院,术后第一周4例(10%)急诊或门诊就诊,6例(15%)术后第1天联系医疗团队。
- 当日出院每例直接成本降低33%,收入成本比149%对比住院组115%。
临床怎么用
- 对于接受多孔机器人辅助简单前列腺切除术的患者,可考虑实施当日出院路径以缩短住院时间并降低机构成本。
局限性
- 仅纳入48例连续患者,样本量有限,且后续分析仅包含当日出院患者,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To prospectively assess the feasibility, safety, and cost-effectiveness of a same-day discharge (SDD) pathway for multiport (MP) robot-assisted simple prostatectomy (RASP). METHODS: Data from 48 consecutive patients undergoing MP-RASP between July 2021 and August 2025 were prospectively collected. All patients followed an Enhanced Recovery After Surgery protocol. We utilized a bladder neck-sparing technique with a transperitoneal approach and robotic transversus abdominis plane block. Healthcare utilization data consisted of postoperative calls/messages and unplanned visits. We also report average institutional costs for SDD versus inpatient RASP. RESULTS: Forty of forty-eight (83%) patients were discharged same-day. Eight (17%) stayed overnight: 6 for patient preference and 2 for hematuria. Subsequent analyses included SDD patients only. The median operative time was 131 (115-147) minutes, and the median length of hospital stay was 141 (114-173) minutes with a median pain score at discharge of 3 (0-4). Two (5%) patients were readmitted within 30 days. During the first week, 4 (10%) patients visited the emergency room or clinic. Six (15%) patients contacted their care team on postoperative day 1 (3 for medication-related questions, 2 for catheter issues, and 1 regarding surgery). The direct cost per case was 33% lower for SDD RASP, with a greater revenue-to-cost ratio at 149% compared to 115%. CONCLUSION: MP-RASP with SDD is safe and feasible, providing favorable outcomes with reduced hospital stay and lower costs.
引用
- Khanmammadova N, Wang J, Jiang D, et al. Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization. Urology. 2026. PMID: 42365879. doi:10.1016/j.urology.2026.06.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。